Follicular dendritic cell sarcoma arising in the dura mater of the spine

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 11, 2006, Pages 1718-1721

  Choi, Jung Woo ^a   Lee, Ju Han ^a   Kim, Aeree ^a   Kim, Chul Hwan ^a   Chae, Yang Seok ^a   Kim, Insun ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD23 ANTIGEN; CD68 ANTIGEN; CD79A ANTIGEN; CLUSTERIN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR;

AGED; ARTICLE; CANCER LOCALIZATION; CASE REPORT; CLINICAL FEATURE; DENDRITIC CELL; DURA MATER; EPIDURAL SPACE; FOLLICULAR DENDRITIC CELL SARCOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LOW BACK PAIN; LYMPH FOLLICLE; LYMPHOCYTIC INFILTRATION; MALE; RARE DISEASE; SARCOMA; SPINDLE CELL; SPINE; TUMOR CELL;

AGED; DENDRITIC CELLS, FOLLICULAR; DURA MATER; GENE REARRANGEMENT; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOHISTOCHEMISTRY; LOW BACK PAIN; MAGNETIC RESONANCE IMAGING; MALE; NEUROSURGICAL PROCEDURES; RNA, MESSENGER; SARCOMA; SPINAL CORD NEOPLASMS; STAINING AND LABELING;

EID: 33750578092     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Weiss L, Dura T, Grogan T, et al. Follicular dendritic cell sarcoma/tumour. In: Jaffe ES, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue. Lyon, France: IARC Press, 2001;286-288.
2. World Health Organization classification of Tumors; vol 3.
3. Chan JK, Fletcher CD, Nayler SJ, Cooper K. Follicular dendritic cell sarcoma: clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer. 1997;79:294-313.
4. Perez-Ordonez B, Erlandson RA, Rosai J. Follicular dendritic cell tumor: report of 13 additional cases of a distinctive entity. Am J Surg Pathol. 1996;20:944-955.
5. Monda L, Warnke R, Rosai J. A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation: a report of 4 cases. Am J Pathol. 1986;122:562-572.
6. Chan AC, Chan KW, Chan JK, Au WY, Ho WK, Ng WM. Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: tracing its evolution by sequential biopsies. Histopathology. 2001;38:510-518.
7. Ruco LP, Gearing AJ, Pigott R, et al. Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic reticulum cells. Histopathology. 1991;19:523-528.
8. Pauwels P, Dal Cin P, Vlasveld LT, Aleva RM, van Erp WF, Jones D. A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells. Am J Surg Pathol. 2000;24:882-888.
9. Sun X, Chang KC, Abruzzo LV, Lai R, Younes A, Jones D. Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman's disease. Hum Pathol. 2003;34:835-840.
10. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A. 1984;81:4510-4514.
11. Lindhout E, Lakeman A, Mevissen ML, de Groot C. Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines. J Exp Med. 1994;179:1173-1184.
12. Selves J, Meggetto F, Brousset P, et al. Inflammatory pseudotumor of the liver: evidence of follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus. Am J Surg Pathol. 1996;20:747-753.